The unconditioned fear produced by morphine withdrawal is regulated by μ- and κ-opioid receptors in the midbrain tectum

Behavioural Brain Research

Volumn 204, Issue 1, 2009, Pages 140-146

  De Ross, Jana ^a,b   Ávila, Milton A V ^a,b   Ruggiero, Rafael N ^a,b   Nobre, Manoel J ^a,b   Brandão, Marcus L ^a,b   Castilho, Vanessa M ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Neuroscience and Behavior   (Brazil)

Author keywords

Anxiety; Dorsal periaqueductal gray; Fear; Inferior colliculus; Morphine withdrawal; Opioid receptors

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; MORPHINE SULFATE; MU OPIATE RECEPTOR; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; ELECTRODE; ELECTROSTIMULATION; ESCAPE BEHAVIOR; FEAR; FREEZING TOLERANCE; INFERIOR COLLICULUS; MALE; MESENCEPHALON; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TECTUM; TREATMENT DURATION; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; CATHETERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ESCAPE REACTION; FEAR; FREEZING REACTION, CATALEPTIC; MALE; MICROINJECTIONS; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SUBSTANCE WITHDRAWAL SYNDROME; TECTUM MESENCEPHALI;

EID: 67849103573     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.05.033     Document Type: Article

References (56)

1. Adriani W., and Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol 15 (2004) 341-352
2. Anseloni V.C., Coimbra N.C., Morato S., and Brandao M.L. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test. Exp Brain Res 129 (1999) 260-268
3. Ávila M.A., Ruggiero R.N., Cabral A., Brandão M.L., Nobre M.J., and Castilho V.M. Involvement of the midbrain tectum in the unconditioned fear promoted by morphine withdrawal. Eur J Pharmacol 590 (2008) 217-223
4. Bals-Kubik R., Ableitner A., Herz A., and Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264 (1993) 489-495
5. Bals-Kubik R., Herz A., and Shippenberg T.S. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology (Berl) 98 (1989) 203-206
6. Bandler R., and Shipley M.T. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci 17 (1994) 379-389
7. Bellchambers C.E., Chieng B., Keay K.A., and Christie M.J. Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla. Neuroscience 83 (1998) 517-524
8. Bigelow G.E., Preston K.L., and Opioids. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: the fourth generation of the progress (1995), Raven, New York 1731-1744
9. Birch P.J., Hayes A.G., Sheehan M.J., and Tyers M.B. Norbinaltorphimine: antagonist profile at kappa opioid receptors. Eur J Pharmacol 144 (1987) 405-408
10. Bozarth M.A., and Wise R.A. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224 (1984) 516-517
11. Brandão M.L. Involvement of opioid mechanisms in the dorsal periaqueductal gray in drug abuse. Rev Neurosci 4 (1993) 397-405
12. Brandão M.L., Anseloni V.Z., Pandossio J.E., De Araujo J.E., and Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci Biobehav Rev 23 (1999) 863-875
13. Brandão M.L., de Aguiar J.C., and Graeff F.G. GABA mediation of the anti-aversive action of minor tranquilizers. Pharmacol Biochem Behav 16 (1982) 397-402
14. Brandão M.L., Tomaz C., Borges P.C., Coimbra N.C., and Bagri A. Defense reaction induced by microinjections of bicuculline into the inferior colliculus. Physiol Behav 44 (1988) 361-365
15. Busto U.E., and Sellers E.M. Anxiolytics and sedative/hypnotics dependence. Br J Addict 86 (1991) 1647-1652
16. Cabral A., Isoardi N., Salum C., Macedo C.E., Nobre M.J., Molina V.A., et al. Fear state induced by ethanol withdrawal may be due to the sensitization of the neural substrates of aversion in the dPAG. Exp Neurol 200 (2006) 200-208
17. Campbell J.O., Wood R.D., and Spear L.P. Cocaine and morphine-induced place conditioning in adolescent and adult rats. Physiol Behav 68 (2000) 487-493
18. Cardoso S.H., Melo L., Coimbra N.C., and Brandão M.L. Opposite effects of low and high doses of morphine on neural substrates of aversion in the inferior colliculus. Behav Pharmacol 3 (1992) 489-495
19. Castilho V.M., Avanzi V., and Brandão M.L. Antinociception elicited by aversive stimulation of the inferior colliculus. Pharmacol Biochem Behav 62 (1999) 425-431
20. Castilho V.M., Borelli K.G., Brandão M.L., and Nobre M.J. Anxiety-like symptoms induced by morphine withdrawal may be due to the sensitization of the dorsal periaqueductal grey. Physiol Behav 94 (2008) 552-562
21. Chambers R.A., Taylor J.R., and Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 160 (2003) 1041-1052
22. Depaulis A., Bandler R., and Vergnes M. Characterization of pretentorial periaqueductal gray matter neurons mediating intraspecific defensive behaviors in the rat by microinjections of kainic acid. Brain Res 486 (1989) 121-132
23. Fontanesi L.B., Ferreira R., Cabral A., Castilho V.M., Brandão M.L., and Nobre M.J. Brainstem areas activated by diazepam withdrawal as measured by Fos-protein immunoreactivity in rats. Brain Res 1166 (2007) 35-46
24. Frenois F., Cador M., Caille S., Stinus L., and Le Moine C. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16 (2002) 1377-1389
25. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science 251 (1991) 1580-1586
26. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 28 (2004) 239-259
27. Hacker J., Pedersen N.P., Chieng B.C., Keay K.A., and Christie M.J. Enhanced Fos expression in glutamic acid decarboxylase immunoreactive neurons of the mouse periaqueductal grey during opioid withdrawal. Neuroscience 137 (2006) 1389-1396
28. Ingram S.L., Fossum E.N., and Morgan M.M. Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats. Neuropsychopharmacology 32 (2007) 600-606
29. Jaffe J.H. Drug addiction and abuse. In: Gilman A.G., Rall T.W., Nies A.S., and Taylor P. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics (1990), Pergamon Press, New York 522-573
30. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
31. Maldonado R., Stinus L., Gold L.H., and Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261 (1992) 669-677
32. Markou A., Kosten T.R., and Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18 (1998) 135-174
33. Melo L.L., Cardoso S.H., and Brandão M.L. Antiaversive action of benzodiazepines on escape behavior induced by electrical stimulation of the inferior colliculus. Physiol Behav 51 (1992) 557-562
34. Motta V., and Brandão M.L. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol Biochem Behav 44 (1993) 119-125
35. Motta V., Penha K., and Brandão M.L. Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test. Psychopharmacology (Berl) 120 (1995) 470-474
36. Narita M., Funada M., and Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89 (2001) 1-15
37. Nashold Jr. B.S., Wilson W.P., and Slaughter D.G. Sensations evoked by stimulation in the midbrain of man. J Neurosurg 30 (1969) 14-24
38. Nobre M.J., Ribeiro dos S.N., Aguiar M.S., and Brandão M.L. Blockade of mu- and activation of kappa-opioid receptors in the dorsal periaqueductal gray matter produce defensive behavior in rats tested in the elevated plus-maze. Eur J Pharmacol 404 (2000) 145-151
39. Osaki M.Y., Castellan-Baldan L., Calvo F., and Carvalho A.D. Felippotti TT, de OR et al. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus. Brain Res 992 (2003) 179-192
40. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (2005), Elsevier, San Diego
41. Philpot R.M., and Kirstein C.L. The effects of repeated alcohol exposure on the neurochemistry of the periadolescent nucleus accumbens septi. Neuroreport 9 (1998) 1359-1363
42. Philpot R.M., and Kirstein C.L. Repeated cocaine exposure: effects on catecholamines in the nucleus accumbens septi of periadolescent animals. Pharmacol Biochem Behav 62 (1999) 465-472
43. Sante A.B., Nobre M.J., and Brandão M.L. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behav Pharmacol 11 (2000) 583-589
44. Schulteis G., and Koob G.F. Reinforcement processes in opiate addiction: a homeostatic model. Neurochem Res 21 (1996) 1437-1454
45. Schulteis G., Markou A., Gold L.H., Stinus L., and Koob G.F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271 (1994) 1391-1398
46. Schulteis G., Yackey M., Risbrough V., and Koob G.F. Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Behav 60 (1998) 727-731
47. Shram M.J., Siu E.C., Li Z., Tyndale R.F., and Le A.D. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats. Psychopharmacology (Berl) 198 (2008) 181-190
48. Sim-Selley L.J., Selley D.E., Vogt L.J., Childers S.R., and Martin T.J. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20 (2000) 4555-4562
49. Smith R.F. Animal models of periadolescent substance abuse. Neurotoxicol Teratol 25 (2003) 291-301
50. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24 (2000) 417-463
51. Spear L.P., and Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 16 (1983) 83-109
52. Spear L.P., Horowitz G.P., and Lipovsky J. Altered behavioral responsivity to morphine during the periadolescent period in rats. Behav. Brain Res 4 (1982) 279-288
53. Stinus L., Caille S., and Koob G.F. Opiate withdrawal-induced place aversion lasts for up to 16 weeks. Psychopharmacology (Berl) 149 (2000) 115-120
54. Stinus L., Le Moal M., and Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37 (1990) 767-773
55. Van Ree J.M., Gerrits M.A., and Vanderschuren L.J. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 51 (1999) 341-396
56. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annu Rev Biochem 73 (2004) 953-990